Form 4: Rallybio Corp Director Ronald Hunt Acquires Options

Director Ronald Hunt acquired options to purchase 16,500 shares of Rallybio Corp common stock on May 15, 2024.

Summary

• On May 15, 2024, Ronald Hunt, a director of Rallybio Corp, acquired options to purchase 16,500 shares of the company's common stock.
• The options were granted under the company's 2021 Equity Incentive Plan.
• The exercise price of the options is $1.91.
• The options vest on the earlier of May 15, 2025, or the date of the company's 2025 Annual Meeting of Stockholders.
• The options expire on May 15, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of stock options, which can be seen as a positive sign of alignment with shareholder interests, but doesn't provide enough information to strongly influence sentiment.

Positives

• The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.

Stakeholder Impact

• The acquisition of options by a director could have a slightly positive impact on shareholders, as it aligns the director's interests with those of the shareholders.

Key Dates